Norepinephrine Bitartrate recalls
Norepinephrine Bitartrate products have been recalled 2 times, most recently on 28 Feb 2024. The recalling company is usually Sun Pharmaceutical Industries. The most common reason is packaging defects.
Total recalls2since 2023
Last 12 months0reported
Class I00% of total
Ongoing1latest 28 Feb 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why norepinephrine bitartrate is recalled
Companies
Product types
By year
Ongoing norepinephrine bitartrate recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg recalledNorepinephrine Bitartrate | Baxter Healthcare | Packaging Defects | Nationwide |
All norepinephrine bitartrate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg recalledNorepinephrine Bitartrate | Baxter Healthcare | Packaging Defects | Nationwide |
| Drug | CLASS III | Norepinephrine Bitartrate Injection, USP, 4 mg/* recalledNorepinephrine Bitartrate | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.